REQUEST A DEMO
Total
USD $0.00
Search more companies

Abl Bio Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Abl Bio Inc. Profile Updated: July 06, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a company mainly engaged in the development of biopharmaceuticals. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.
The Company was established on February 16, 2016. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on December 19, 2018.

Headquarters
2F, 16, Daewangpangyyo-Ro 712Beon-Gil, Bundang-Gu, Seongnam-Si, Gyeonggi-Do
Seongnam; Gyeonggi;

Contact Details: Purchase the Abl Bio Inc. report to view the information.

Website: http://www.ablbio.com

Basic Information
Total Employees:
Purchase the Abl Bio Inc. report to view the information.
Outstanding Shares:
Purchase the Abl Bio Inc. report to view the information.
Registered Capital:
Purchase the Abl Bio Inc. report to view the information.
Financial Auditors:
Purchase the Abl Bio Inc. report to view the information.
Incorporation Date:
February 16, 2016
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
28.1%
Purchase this report to view the information.
12.2%
Purchase this report to view the information.
1.5%
Subsidiaries
에이비엘바이오(주)
Company Performance
Financial values in the chart are available after Abl Bio Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-80.34%
Total operating revenue
-79.83%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-30.63%
Total equity
-33.47%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
25.02%
Quick Ratio
0.74%
Cash Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?